Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in osmotic agents for peritoneal dialysis

W Van Biesen1, R Vanholder, N Lameire

  • 1Department of Internal Medicine, University Hospital, Gent, Belgium.

Advances in Renal Replacement Therapy
|August 1, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wars, disasters and kidneys.

Acta clinica Belgica·2014
Same author

What is the difference between prerenal and renal acute kidney injury?

Acta clinica Belgica·2012
Same author

Nephrotoxicity of anticancer drugs--an underestimated problem?

Acta clinica Belgica·2011
Same author

A unifying hypothesis and a single name for a complex globally emerging infection: hantavirus disease.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011
Same author

Characteristics, cardiovascular comorbidity and medicines management in patients with type 2 diabetes and CKD: results of the IRIDIEM study.

Kidney & blood pressure research·2010
Same author

Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS).

Acta clinica Belgica·2008
Same journal

Needed: a catalyst for change.

Advances in renal replacement therapy·2004
Same journal

Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children.

Advances in renal replacement therapy·2004
Same journal

Incorporating ethnic and cultural food preferences in the renal diet.

Advances in renal replacement therapy·2004
Same journal

Literature review and implications for social work practice with Hispanic dialysis patients.

Advances in renal replacement therapy·2004
Same journal

Diversity and patient care in a shrinking world.

Advances in renal replacement therapy·2004
Same journal

Genetic variation in the epithelial sodium channel: a risk factor for hypertension in people of African origin.

Advances in renal replacement therapy·2004
See all related articles

Glucose is common for peritoneal dialysis but has drawbacks. Alternative osmotic agents are being studied for better biocompatibility, nutrition, and long-term ultrafiltration, with mixtures showing future promise.

Area of Science:

  • Nephrology
  • Biomaterials Science

Background:

  • Glucose is the primary osmotic agent in peritoneal dialysis but presents long-term challenges.
  • Several alternative non-glucose molecules have been investigated for peritoneal dialysis, each with unique benefits and limitations.

Purpose of the Study:

  • To review alternative osmotic agents for peritoneal dialysis.
  • To discuss their potential indications, drawbacks, and impact on peritoneal membrane integrity and function.

Main Methods:

  • Review of current literature on non-glucose osmotic agents for peritoneal dialysis.
  • Analysis of performance, biocompatibility, and long-term safety data.

Main Results:

  • Alternative agents offer advantages over glucose but also have drawbacks.

Related Experiment Videos

  • Key considerations include improving biocompatibility with physiologic pH, enhancing nutritional status with amino acids, and maintaining ultrafiltration with polyglucose.

    • Conclusions:

    • Careful testing of new agents for performance and safety is crucial.
    • Future peritoneal dialysis solutions may utilize mixtures of osmotic agents for optimal outcomes.